Market capitalization | $2.27b |
Enterprise Value | $2.61b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 25.54 |
EV/Sales (TTM) EV/Sales | 2.04 |
P/S ratio (TTM) P/S ratio | 1.77 |
P/B ratio (TTM) P/B ratio | 1.56 |
Revenue growth (TTM) Revenue growth | 16.31% |
Revenue (TTM) Revenue | $1.28b |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
8 Analysts have issued a LifeStance Health Group Inc forecast:
8 Analysts have issued a LifeStance Health Group Inc forecast:
Mar '25 |
+/-
%
|
||
Revenue | 1,284 1,284 |
16%
16%
|
|
Gross Profit | 355 355 |
46%
46%
|
|
EBITDA | 50 50 |
157%
157%
|
EBIT (Operating Income) EBIT | -13 -13 |
93%
93%
|
Net Profit | -36 -36 |
79%
79%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Lifestance Health Group, Inc. operates a holding company. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.
Head office | United States |
CEO | David Bourdon |
Employees | 10,218 |
Founded | 2017 |
Website | lifestance.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.